MARKET

NSPR

NSPR

Inspiremd
NASDAQ
1.640
+0.050
+3.14%
Opening 15:10 03/30 EDT
OPEN
1.600
PREV CLOSE
1.590
HIGH
1.650
LOW
1.580
VOLUME
10.78K
TURNOVER
--
52 WEEK HIGH
2.932
52 WEEK LOW
1.510
MARKET CAP
76.75M
P/E (TTM)
-2.1623
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NSPR last week (0323-0327)?
Weekly Report · 10h ago
Weekly Report: what happened at NSPR last week (0316-0320)?
Weekly Report · 03/23 09:34
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (JNJ) and InspireMD (NSPR)
TipRanks · 03/19 13:10
InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption
TipRanks · 03/19 06:02
InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction
Seeking Alpha · 03/18 16:33
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
TipRanks · 03/18 16:02
BUZZ-U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies
Reuters · 03/18 15:47
BUZZ-InspireMD rises after quarterly revenue beat
Reuters · 03/18 13:40
More
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Webull offers InspireMD Inc stock information, including NASDAQ: NSPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NSPR stock methods without spending real money on the virtual paper trading platform.